BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5755772)

  • 1. [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)].
    Karasawa Y
    Sanfujinka No Jissai; 1968 Oct; 17(10):913-8. PubMed ID: 5755772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
    Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
    Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC; Kaufman RH
    Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysmenorrhoea unrelieved by an oral contraceptive.
    Practitioner; 1968 Jun; 200(200):856-9. PubMed ID: 4871666
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial use of Sophia-32].
    Kanazawa Y
    Horumon To Rinsho; 1969 Jul; 17(7):611-4. PubMed ID: 5390067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)].
    Ueda Y; Hayashi K; Maruo M; Fujii O; Yagi T
    Saishin Igaku; 1965 Dec; 20(12):3234-53 passim. PubMed ID: 5869520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
    Müller R; Kempf HJ; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of dysmenorrhea].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1984 Jan; 63(1):12-4. PubMed ID: 6228751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactation inhibition by norethindrone with mestranol.
    Nickerson CW; Berkman VO
    Rocky Mt Med J; 1967 Jun; 64(6):53-4. PubMed ID: 6044157
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effectiveness of norethindrone-mestranol in dysfunctional uterine bleeding].
    Reyes Ceja L; Zarate A; Guerrero A
    Ginecol Obstet Mex; 1968 Jan; 23(135):103-7. PubMed ID: 5674323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome].
    Roll H; Breckwoldt M; Amann K
    Arch Gynecol; 1979 Jul; 228(1-4):575-6. PubMed ID: 485482
    [No Abstract]   [Full Text] [Related]  

  • 13. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic utility of norethindrone-mestranol in abnormal uterine bleeding.
    McDonough PG; Greenblatt RB
    Obstet Gynecol; 1966 Apr; 27(4):480-3. PubMed ID: 5907368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acne in male patients with anovulatory compounds].
    Porto JA; Abreu J
    Hospital (Rio J); 1965 Jun; 67(6):1211-5. PubMed ID: 4221295
    [No Abstract]   [Full Text] [Related]  

  • 16. Progestin-estrogen combinations in management of acne.
    Kostant GH
    J Med Soc N J; 1965 Nov; 62(11):523-6. PubMed ID: 4220687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of Non-ovlon in female patients with acne vulgaris].
    Klinger G; Reich P; Hempel E
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1202-5. PubMed ID: 4251329
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential mestranol and morethisterone in the treatment of the climacteric syndrome.
    Moore B
    Postgrad Med J; 1976; 52 Suppl 6():39-47. PubMed ID: 981118
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
    Fiorino S; Rossi T; Scio A
    Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D; Moore B; Williams JG; Studd JW; Bradwell AR
    Postgrad Med J; 1976; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.